Naphthalimides exhibit in vitro antiproliferative and antiangiogenic activities by inhibiting both topoisomerase II (topo II) and receptor tyrosine kinases (RTKs)
Author:
Xin Wang,Zhuo Chen,Linjiang Tong,Shaoying Tan,Wei Zhou,Ting Peng,Kun Han,Jian Ding,Hua Xie,Yufang Xu
Publication:
European Journal of Medicinal Chemistry
Copyright © 2013 Elsevier Masson SAS. All rights reserved.